CIBC Asset Management
SLDB icon

CIBC Asset Management’s Solid Biosciences SLDB Stock Holding History

CIBC Asset Management’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-12,083
Closed -$63.3K – 1093
2023
Q2 		$63.3K Hold
12,083
– – ﹤0.01% 1052
2023
Q1 		$57.3K Buy
+12,083
New +$72.6K ﹤0.01% 1014

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIBC Asset Management's SLDB Position: Q3 2023 in Review

CIBC Asset Management sold out of Solid Biosciences (SLDB) in Q3 2023, closing a stake of 12,083 shares — an estimated $63.3K sold.

CIBC Asset Management first reported a position in SLDB in Q1 2023 and held it in 2 quarters. The position peaked at $63.3K in Q2 2023. 36 funds tracked by Wall St. Rank hold SLDB as of Q3 2023.

  • CIBC Asset Management reported no remaining Solid Biosciences position as of Q3 2023 after selling out during the quarter.
  • CIBC Asset Management sold 12,083 Solid Biosciences shares in Q3 2023, an estimated $63.3K.
  • CIBC Asset Management first reported a position in Solid Biosciences in Q1 2023 and held it in 2 quarters.
  • CIBC Asset Management's Solid Biosciences position peaked at $63.3K in Q2 2023.
  • 36 funds tracked by Wall St. Rank held Solid Biosciences as of Q3 2023.

Based on CIBC Asset Management's 13F filing for Q3 2023, filed 30 Oct 2023.